Stay updated on Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now includes the study documents (SAP, Study Protocol) and IPD sharing plan, along with related metadata updates, which contextualize the trial's methodology and governance.
    Difference
    80%
    Check dated 2026-09-27T07:54:16.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added, and the page's Study Documents section was significantly reduced, removing items such as Statistical Analysis Plan and Study Protocol.
    Difference
    18%
    Check dated 2026-09-20T03:12:00.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 on the page, indicating a software version increment. No visible changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-08-29T23:55:40.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the page template or metadata. This change does not modify the study content or results displayed.
    Difference
    0.0%
    Check dated 2026-08-08T23:24:41.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.6.3 to v3.6.4. This reflects a new build or update to the page content rather than a substantive change.
    Difference
    0.0%
    Check dated 2026-07-25T17:12:01.000Z thumbnail image
  7. Check
    94 days ago
    Change Detected
    Summary
    The page displays Revision: v3.6.3 in place of Revision: v3.6.2, indicating a version update to the page. This change represents a metadata refresh (e.g., template or content adjustments) without altering the study details presented.
    Difference
    0.0%
    Check dated 2026-07-04T05:17:02.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Urticaria: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Urticaria: Clinical Trial page.